Hot Features
프리미엄
Entero Therapeutics Inc (ENTO)
NASDAQ
같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
BOCA RATON, Fla., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...
BOCA RATON, Fla., Aug. 23, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...
BOCA RATON, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing...
New VCIEL scale provides a more sensitive and quantitative metric of small intestinal health for monitoring Celiac Disease severity and treatment efficacy Special editorial highlights the...
BOCA RATON, Fla., May 22, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc. (formerly First Wave BioPharma, Inc.) (Nasdaq: ENTO) (“Entero” or the “Company”), a late clinical-stage...
BOCA RATON, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- Entero Therapeutics, Inc., (NASDAQ: ENTO), (“Entero Therapeutics” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
| 기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.096 | 32.8767123288 | 0.292 | 0.46 | 0.2501 | 251048 | 0.39161183 | CS |
| 4 | -1.642 | -80.8866995074 | 2.03 | 2.19 | 0.185 | 634922 | 0.38810345 | CS |
| 12 | -2.572 | -86.8918918919 | 2.96 | 3.16 | 0.185 | 461756 | 0.41872557 | CS |
| 26 | -2.572 | -86.8918918919 | 2.96 | 3.16 | 0.185 | 461756 | 0.41872557 | CS |
| 52 | -2.572 | -86.8918918919 | 2.96 | 3.16 | 0.185 | 461756 | 0.41872557 | CS |
| 156 | -2.572 | -86.8918918919 | 2.96 | 3.16 | 0.185 | 461756 | 0.41872557 | CS |
| 260 | 0 | 0 | 0 | 0.46 | 0 | 0 | 0 | CS |
glenn1919
5 일 전
gail
1 월 전
TheFinalCD
1 월 전
gail
1 월 전
gail
1 월 전
glenn1919
1 월 전
